Laboratoires URGO led the France cough remedies market in 2012, accounting for a 13% share of value sales. Its key range of Humex branded products continued to remain dynamic in 2012, despite a mitigated flu season, and especially thanks to its very broad coverage of more than 15 products in all the different categories within cold, cough and allergy (hay fever) remedies. Besides, Humex enjoys the highest brand recognition in France for such products, with almost 86% of the population being very familiar with Humex products.
Overall value sales of cough, cold and allergy (hay fever) remedies remained rather stable in 2012 when compared with 2011. Antihistamines/allergy remedies saw slightly faster growth, whilst the growth rate for pharyngeal preparations remained positive, but was slightly lower than the 1% current value growth in 2011.
Over the forecast period cough, cold and allergy (hay fever) remedies is expected to see a negative constant value CAGR of 1%, for two main reasons: a shift in consumption pattern towards generics, which are generally sold at lower price; and an ever-increasing plethora of alternative products (such as homeopathic products), which will continue to intensify the competition and drive down prices as well as overall value sales. Finally, a general preference for preventive (rather than curative) products/measures/habits will put a further brake on the demand for curative medicines.
For more information on the France cough remedies market, please click here: France cough remedies market
Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.